Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.
作者信息
Russell Clark D, Millar Jonathan E, Baillie J Kenneth
机构信息
University of Edinburgh Centre for Inflammation Research, The Queen's Medical Research Institute Edinburgh, Edinburgh, UK.
Genetics and Genomics, Roslin Institute, University of Edinburgh, Edinburgh EH25 9RG, UK.
出版信息
Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7.
Abstract
摘要
相似文献
1
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.临床证据不支持使用皮质类固醇治疗2019新型冠状病毒肺炎肺损伤。
Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7.
2
[Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia].《2019新型冠状病毒肺炎患者使用糖皮质激素的专家共识》
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):183-184. doi: 10.3760/cma.j.issn.1001-0939.2020.03.008.
3
What can we learn about corticosteroid therapy as a treatment for COVID-19?关于皮质类固醇疗法作为治疗新冠肺炎的方法，我们能了解到什么？
Osteoporos Int. 2020 Aug;31(8):1595. doi: 10.1007/s00198-020-05487-w. Epub 2020 Jun 9.
4
Dexamethasone in the management of covid -19.地塞米松在新冠病毒病治疗中的应用
BMJ. 2020 Jul 3;370:m2648. doi: 10.1136/bmj.m2648.
5
On the use of corticosteroids for 2019-nCoV pneumonia.关于皮质类固醇在2019新型冠状病毒肺炎中的应用。
Lancet. 2020 Feb 29;395(10225):683-684. doi: 10.1016/S0140-6736(20)30361-5. Epub 2020 Feb 12.
6
Glucocorticoid-Induced Bacterial Endocarditis in COVID-19 Pneumonia - Something to Be Concerned About?新冠病毒肺炎中糖皮质激素诱导的细菌性心内膜炎——值得关注吗？
Circ J. 2020 Sep 25;84(10):1887. doi: 10.1253/circj.CJ-20-0462. Epub 2020 Aug 7.
7
[Glucocorticoid for coronavirus disease 2019: a dilemma].[2019冠状病毒病的糖皮质激素治疗：一个两难困境]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Mar;32(3):278. doi: 10.3760/cma.j.cn121430-20200309-00352.
8
Therapeutic potential of ciclesonide inahalation for COVID-19 pneumonia: Report of three cases.三例 COVID-19 肺炎患者采用环索奈德雾化吸入治疗的疗效观察
J Infect Chemother. 2020 Jun;26(6):625-632. doi: 10.1016/j.jiac.2020.04.007. Epub 2020 Apr 16.
9
COVID-19: The Uninvited Guest in the Intensive Care Unit - Implications for Pharmacotherapy.新型冠状病毒肺炎：重症监护病房中的不速之客——对药物治疗的影响
Pharmacotherapy. 2020 May;40(5):382-386. doi: 10.1002/phar.2394. Epub 2020 May 4.
10
Research Progress of Drug Treatment in Novel Coronavirus Pneumonia.新型冠状病毒肺炎的药物治疗研究进展。
AAPS PharmSciTech. 2020 May 13;21(4):130. doi: 10.1208/s12249-020-01679-z.
引用本文的文献
1
Drug utilisation patterns & clinical outcomes in hospitalised COVID-19 patients: A geospatial & machine learning approach.住院COVID-19患者的药物使用模式及临床结局：一种地理空间与机器学习方法。
Indian J Med Res. 2025 Apr;161(4):375-385. doi: 10.25259/IJMR_352_24.
2
Dual threat: Susceptibility mechanisms and treatment strategies for COVID-19 and bacterial co-infections.双重威胁：新型冠状病毒肺炎与细菌合并感染的易感性机制及治疗策略
Comput Struct Biotechnol J. 2025 May 22;27:2107-2122. doi: 10.1016/j.csbj.2025.05.033. eCollection 2025.
3
Feature Importance Analysis by Nowcasting Perspective to Predict COVID-19.基于临近预报视角的特征重要性分析以预测新冠肺炎
Mob Netw Appl. 2022;27(5):1967-1976. doi: 10.1007/s11036-022-01966-y. Epub 2022 Apr 23.
4
[Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology].[关于在SARS-CoV-2/COVID-19感染背景下成年风湿性疾病患者管理的建议。哥伦比亚风湿病协会]
Rev Colomb Reumatol. 2020 Jul-Sep;27(3):230-241. doi: 10.1016/j.rcreu.2020.05.007. Epub 2020 Jun 12.
5
Revisiting the role of steroidal therapeutics in the 21st century: an update on FDA approved steroidal drugs (2000-2024).重新审视甾体疗法在21世纪的作用：美国食品药品监督管理局批准的甾体药物（2000 - 2024年）最新情况
RSC Med Chem. 2025 May 8. doi: 10.1039/d5md00027k.
6
The comparative effectiveness of methylprednisolone versus dexamethasone on in-hospital mortality in patients with severe or critical COVID-19: a retrospective observational study.甲泼尼龙与地塞米松对重症或危重症新型冠状病毒肺炎患者院内死亡率的比较疗效：一项回顾性观察研究
Ther Adv Infect Dis. 2025 Apr 22;12:20499361251328824. doi: 10.1177/20499361251328824. eCollection 2025 Jan-Dec.
7
B cells modulate lung antiviral inflammatory responses via the neurotransmitter acetylcholine.B细胞通过神经递质乙酰胆碱调节肺部抗病毒炎症反应。
Nat Immunol. 2025 May;26(5):775-789. doi: 10.1038/s41590-025-02124-8. Epub 2025 Apr 22.
8
Examining efficacy and safety of ethyl acetate extract from as complementary therapy in COVID-19: A randomized, multicenter, controlled clinical trial.考察[具体植物名称]乙酸乙酯提取物作为COVID-19辅助疗法的疗效和安全性：一项随机、多中心、对照临床试验。 （注：原文中“as complementary therapy in COVID-19”前缺少具体植物名称，翻译时添加了[具体植物名称]以保证句子完整通顺）
Avicenna J Phytomed. 2024 Nov-Dec;14(6):699-710. doi: 10.22038/AJP.2024.24523.
9
Deep insight into cytokine storm: from pathogenesis to treatment.深入洞察细胞因子风暴：从发病机制到治疗。
Signal Transduct Target Ther. 2025 Apr 16;10(1):112. doi: 10.1038/s41392-025-02178-y.
10
Pharmacological validation of a novel exopolysaccharide from sp. 139 to effectively inhibit cytokine storms.对来自菌株139的一种新型胞外多糖有效抑制细胞因子风暴的药理学验证。
Heliyon. 2024 Jul 9;10(14):e34392. doi: 10.1016/j.heliyon.2024.e34392. eCollection 2024 Jul 30.
本文引用的文献
1
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
2
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
3
Pharmacological agents for adults with acute respiratory distress syndrome.用于成人急性呼吸窘迫综合征的药物制剂。
Cochrane Database Syst Rev. 2019 Jul 23;7(7):CD004477. doi: 10.1002/14651858.CD004477.pub3.
4
The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis.糖皮质激素对流感病毒性肺炎患者病死率的影响：系统评价和荟萃分析。
Crit Care. 2019 Mar 27;23(1):99. doi: 10.1186/s13054-019-2395-8.
5
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock.氢化可的松联合氟氢可的松治疗脓毒性休克成人患者。
N Engl J Med. 2018 Mar 1;378(9):809-818. doi: 10.1056/NEJMoa1705716.
6
Adjunctive Glucocorticoid Therapy in Patients with Septic Shock.辅助糖皮质激素治疗脓毒性休克患者。
N Engl J Med. 2018 Mar 1;378(9):797-808. doi: 10.1056/NEJMoa1705835. Epub 2018 Jan 19.
7
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome.糖皮质激素治疗中东呼吸综合征危重症患者。
Am J Respir Crit Care Med. 2018 Mar 15;197(6):757-767. doi: 10.1164/rccm.201706-1172OC.
8
Middle East Respiratory Syndrome.中东呼吸综合征
N Engl J Med. 2017 Feb 9;376(6):584-594. doi: 10.1056/NEJMsr1408795.
9
The effect of steroid use in hospitalized adults with respiratory syncytial virus-related illness.住院成人呼吸道合胞病毒相关疾病中类固醇使用的效果。
Chest. 2011 Nov;140(5):1155-1161. doi: 10.1378/chest.11-0047. Epub 2011 May 12.
10
Hemodynamic impact of a positive end-expiratory pressure setting in acute respiratory distress syndrome: importance of the volume status.急性呼吸窘迫综合征中呼气末正压水平对血流动力学的影响：容量状态的重要性。
Crit Care Med. 2010 Mar;38(3):802-7. doi: 10.1097/CCM.0b013e3181c587fd.
Zotero 插件